Schroder Investment Management Group now owns 1,560,340 shares of the medical device company's stock worth $37,401,000 after acquiring an additional 24,671 shares during the period. On Monday, October 26 the stock rating was initiated by Leerink Swann with "Outperform".
UBS AG reaffirmed their buy rating on shares of K2M Group Holdings, Inc. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.01. The company now has a Return on Equity (ROE) of -173.8 and a Return on Investment (ROI) of -68.9. The firm had revenue of $65.70 million during the quarter, compared to analyst estimates of $66.26 million. However, the institutional investors are observed to own 0.00% of the total shares. K2M Group Holdings's revenue for the quarter was up 11.0% compared to the same quarter previous year.
COPYRIGHT VIOLATION WARNING: "K2M Group Holdings, Inc". If you are viewing this news story on another site, it was stolen and reposted in violation of United States & global trademark & copyright legislation.
U.S. dropped 751 bombs on Afghanistan in September
The Trump administration is also planning to deploy roughly 3,000 more troops to Afghanistan. According to recently released data from the U.S.
K2M Group Hldngs Cmn (NASDAQ:KTWO) as of recent trade, has shown weekly downbeat performance of -20.13% which was maintained at -20.31% in 1-month period.
KTWO has been the subject of several other research reports.
Among 11 analysts covering K2M Group Holdings (NASDAQ:KTWO), 10 have Buy rating, 0 Sell and 1 Hold. The stock of K2M Group Holdings Inc (NASDAQ:KTWO) earned "Outperform" rating by Cowen & Co on Thursday, August 17.
Myanmar attacks were organized to push out Rohingya
UN Human Rights chief Zeid Ra'ad Al Hussein has described Myanmar's government operations in northern Rakhine as " a textbook example of ethnic cleansing ".
According to the recommendations from 8 analysts stock has mean rating of 1.13 on the shares of K2M Group Hldngs Cmn (NASDAQ:KTWO). On Tuesday, July 18 the stock rating was maintained by Cowen & Co with "Buy". The stock presently has an average rating of Buy and an average target price of $25.60. The stock of K2M Group Holdings Inc (NASDAQ:KTWO) has "Overweight" rating given on Thursday, August 4 by Barclays Capital. The 50 day moving average moved down $-4.93 and the 200 day average went down by -22.94%. The company has market cap of $778.95 million. K2M Group Holdings has a one year low of $16.32 and a one year high of $25.99. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. Price Target plays a critical role when it comes to the analysis of a Stock. They expect $0.85 earnings per share, down 30.89% or $0.38 from last year's $1.23 per share. Dorsey & Whitney Trust CO LLC bought a new stake in shares of K2M Group Holdings during the 2nd quarter valued at approximately $211,000. The quarterly performance for the stock is -26.66%, while the half-yearly performance is -15.82%. It is 0.00% or $0 reaching $2.35 per share. As per Monday, May 9, the company rating was maintained by Credit Suisse. The shares were sold on August 23rd for an average price of $23.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Gregory S. Cole sold 39,357 shares of K2M Group Holdings stock in a transaction that occurred on Friday, August 11th. About shares traded. AdvanSix Inc (NYSE:ASIX) has 0.00% since October 11, 2016 and is. The disclosure for this sale can be found here.
The company's quick ratio for most recent quarter is 1.9 along with current ratio for most recent quarter of 3.3. Hot Stocks Point (HSP) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own.
K2M Group Holdings, Inc.is a medical device firm focused on designing, developing and commercializing spine and minimally invasive technologies and techniques.
Hilarie Burton says Ben Affleck groped her on 'TRL'
While the Justice League actor is yet to respond to the allegations against him, Damon has denied any involvement with the Weinstein scandal.